Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
24 July 2017 |
Main ID: |
ChiCTR-IOR-17012094 |
Date of registration:
|
2017-07-23 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Clinical randomized controlled trial of Growth Hormone for assisted reproductive technology in elderly patients
|
Scientific title:
|
Clinical randomized controlled trial of Growth Hormone for assisted reproductive technology in elderly patients |
Date of first enrolment:
|
2017-08-01 |
Target sample size:
|
A:100;B:100; |
Recruitment status: |
Recruiting |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=20611 |
Study type:
|
Interventional study |
Study design:
|
Randomized parallel controlled trial
|
Phase:
|
Other
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Tianran Song
|
Address:
|
53 Zhongshan Road North, Nanjing, China
|
Telephone:
|
+86 13815432266 |
Email:
|
str99188@126.com |
Affiliation:
|
Reproductive Medicine Center, Nanjing Drum Tower Hospital |
|
Name:
|
Haixiang Sun
|
Address:
|
53 Zhongshan Road North, Nanjing, China
|
Telephone:
|
+86 13851622008 |
Email:
|
stevensunz@163.com |
Affiliation:
|
Reproductive Medicine Center, Nanjing Drum Tower Hospital |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Aged 38 to 42 years old;
2. AFC is greater than or equal to 5;
3. The first time of IVF in our hospital.
Exclusion criteria: 1. Patients with diabetes or cancer.
2. Chromosomal abnormalities.
3. Suffer from severe adenomyosis, endometriosis, intrauterine adhesions and other factors that affect the embryo;
4. implantation obviously;
5. Pregnant contraindicated patients.
Age minimum:
38
Age maximum:
42
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Infertility
|
Intervention(s)
|
A:Using Growth Hormone;B:No use of Growth Hormone;
|
Primary Outcome(s)
|
The number of effective embryos;
|
Secondary Outcome(s)
|
pregnancy rate;Parturition rate;Gn dosage;
|
Source(s) of Monetary Support
|
NA
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|